Trial Profile
A Prospective, Randomized, Double-blind, Double-dummy, Sucralfate Controlled, Multicenter Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Teprenone (Primary) ; Sucralfate
- Indications Gastritis
- Focus Therapeutic Use
- 13 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 13 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Feb 2011 Additional lead trial centres identified as reported by Chinese Clinical Trial Register record.